Author:
McLaughlin Vallerie V.,Langer Anatoly,Tan Mary,Clements Philip J.,Oudiz Ronald J.,Tapson Victor F.,Channick Richard N.,Rubin Lewis J.
Subject
Cardiology and Cardiovascular Medicine,Critical Care and Intensive Care Medicine,Pulmonary and Respiratory Medicine
Reference24 articles.
1. Proceedings of the 4th World Symposium on Pulmonary Hypertension, February 2008, Dana Point, California, USA;J Am Coll Cardiol,2009
2. A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension;Barst;N Engl J Med,1996
3. Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease. A randomized, controlled trial;Badesch;Ann Intern Med,2000
4. Effects of the dual endothelin-receptor antagonist bosentan in patients with pulmonary hypertension: a randomised placebo-controlled study;Channick;Lancet,2001
5. Continuous subcutaneous infusion of treprostinil, a prostacyclin analogue, in patients with pulmonary arterial hypertension: a double-blind, randomized, placebo-controlled trial;Simonneau;Am J Respir Crit Care Med,2002
Cited by
112 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献